Development and validation of the somatic symptom disorder scale: A multicenter study
Acta Psychologica · 2026
DOI: 10.1016/j.actpsy.2026.106543 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Psychologica, 2026. Verfasst von Burak Duruk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Istanbul University Faculty of Literature, Istanbul, Turkey. Electronic address: burak.duruk@istanbul.edu.tr. Hauptthemen laut MEDLINE: Psychometrics, Somatoform Disorders, Psychiatric Status Rating Scales, Medically Unexplained Symptoms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: This study developed and validated the Somatic Symptom Disorder Scale (SSDS) to assess Somatic Symptom Disorder (SSD)-related psychological symptom severity consistent with DSM-5. METHODS: Psychometric analyses were conducted using three samples: (a) an outpatient clinical group (N = 314), (b) a matched nonclinical sample for known-groups validity (N = 80), and (c) a separate nonclinical university sample for test-retest reliability (N = 73). Reliability, Exploratory Factor Analysis (EFA), Confirmatory Factor Analysis (CFA), and convergent and known-groups validity were evaluated. RESULTS: The SSDS demonstrated excellent internal consistency (α = 0.94 total; 0.89-0.93 subscales). Test-retest reliability conducted in a nonclinical university sample (N = 73) indicated strong temporal stability over a two-week interval for the total score (r = 0.83, p < .001) and the Cognitive (r = 0.83, p < .001), Affective (r = 0.77, p < .001), and Behavioral (r = 0.76, p < .001) subscales. EFA supported a three-factor, 33-item structure, which CFA confirmed with acceptable fit (χ2/df = 2.2, RMSEA = 0.063, CFI = 0.90, SRMR = 0.059). Convergent validity was supported through significant correlations with PHQ-15, PHQ-9, GAD-7, WI-7, and SSAS (r = 0.32-0.58, p < .001). Known-groups validity indicated that outpatients had significantly higher SSDS scores than nonclinical university students (t(39) = -8.84, p < .001). CONCLUSION: The SSDS showed promising reliability and validity for assessing DSM-5-consistent psychological features of SSD. Its overall psychometric properties suggest that it may be useful in both clinical and research contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, Istanbul University Faculty of Literature, Istanbul, Turkey. Electronic address: burak.duruk@istanbul.edu.tr.
- Department of Psychology, Istanbul University Faculty of Literature, Istanbul, Turkey. Electronic address: osberk@istanbul.edu.tr.
Zitieren
APA
Duruk, B., & Sertel Berk, Ö. (2026). Development and validation of the somatic symptom disorder scale: A multicenter study. Acta Psychologica. https://doi.org/10.1016/j.actpsy.2026.106543
Vancouver
Duruk B, Sertel Berk Ö. Development and validation of the somatic symptom disorder scale: A multicenter study. Acta Psychologica. 2026. doi:10.1016/j.actpsy.2026.106543
BibTeX
@article{Duruk2026,
author = {Duruk, Burak and Sertel Berk, Özlem},
title = {Development and validation of the somatic symptom disorder scale: A multicenter study},
journal = {Acta Psychologica},
year = {2026},
doi = {10.1016/j.actpsy.2026.106543}
}
EUVIMED